Why Depression Treatment Still Struggles

Psychiatry has been treating patients with largely the same playbook for decades. In this episode, we are talking to Florian Brand, Co-Founder of Atai Life Sciences and a leading entrepreneur in the mental health innovation space. Florian shares why he believes psychiatry has seen very little meaningful progress since the introduction of SSRIs in the 1980s and why patients are still caught in a trial-and-error system. "If we look at psychiatry, we really haven't seen any true disruptive or radical innovation, radical leap forwards for patients in decades." Florian's key insights include: - Psychiatry's Innovation Gap: The last major breakthrough in depression treatment dates back to the late 1980s. - The Trial-and-Error Problem: Many patients spend months cycling through medications before finding one that works. - Why Progress Has Been Slow: Mental health remains one of the most challenging areas in medicine despite rising demand and growing awareness. Tune in now to discover why mental health treatment may be overdue for a breakthrough and how innovators are working to change the future of psychiatry. 🎧 Listen now: https://youtu.be/3Gn0bYt-25Y #MentalHealth #Psychiatry #DepressionTreatment #MentalHealthInnovation #FutureOfHealthcare